[권고등급 (recommendation grade)] - 권고대로 중재했을 때 바라는 결과가 나올 것으로 확신하는 정도. 효과의 크기(magnitude of effect)에 대한 고려는 없음.

[1. 유방암 진료권고안(2008)의 recommendation grade]

- Grade A: 최소 1 개 이상의 무작위 대조시험이 요구되며, 내용의 지속성(consistency)이 있는 경우

- Grade B 잘 고안된 대조시험(CT)의 근거는 있으나, 무작위 대조시험(RCT)의 근거가 없는 경우

- Grade C 권위 있는 전문가의 임상경험이나 전문가로 구성된 위원회에서 발표된 의견에 따른 경우

[2. SIGN의 recommendation grade]

- A: At least one 1++ directly applicable to target population; or many studies 1+ directly applicable to target population and demonstrating consistency

- B: Many 2++ directly applicable to target population and demonstrating consistency; or extrapolated evidence from studies rated as 1++ or 1+

- C: Many 2+ directly applicable to target population and demonstrating consistency; or extrapolated evidence from studies rated as 2++

- D: Evidence level 3 or 4; or extrapolated evidence from studies rated as 2+

[3. USPSTF의 grade definitions] - 2007년 3월 개정

- A: The USPSTF recommends the service. There is high certainty that the net benefit is substantial.

- B: The USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.

- C: The USPSTF recommends against routinely providing the service. There may be considerations that support providing the service in an individual patient. There is at least moderate certainty that the net benefit is small.

- D: The USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits.

- I Statement: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.

[Home]